Bio-Techne (TECH) Gains from Investment Securities (2016 - 2024)

Bio-Techne's Gains from Investment Securities history runs 8 years deep, the most recent figure standing at -$283000.0 for Q3 2023.

• In Q3 2023, Gains from Investment Securities changed N/A year-over-year to -$283000.0; the TTM figure through Jun 2024 stood at -$283000.0 (up 40.04% YoY), while the FY2024 annual figure was -$283000.0, up 40.04% from the prior year.
• Gains from Investment Securities for Q3 2023 stood at -$283000.0, up from -$472000.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $68.0 million in Q2 2021, with the low at -$111.1 million in Q1 2020.
• The 5-year median for Gains from Investment Securities is -$655500.0 (2022), against an average of -$4.8 million.
• The sharpest annual moves came in 2019 and 2020: Gains from Investment Securities jumped 372.34% in 2019, then sank 1086.44% in 2020.
• Bio-Techne's Gains from Investment Securities stood at -$10.5 million in 2019, then surged by 57.27% to -$4.5 million in 2020, then climbed by 26.76% to -$3.3 million in 2021, then surged by 74.58% to -$839000.0 in 2022, then surged by 66.27% to -$283000.0 in 2023.
• Business Quant data shows TECH's Gains from Investment Securities at -$283000.0 in Q3 2023, -$472000.0 in Q2 2023, and $839000.0 in Q1 2023.